阿戈美拉汀治疗首发老年抑郁症的临床疗效研究

Clinical efficacy of agomelatine in the treatmen of first-episode senile depression

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2018, 45(1)
作者
作者单位

青岛大学附属医院心理门诊 ;
青岛市精神卫生中心 ;
青岛大学附属医院 ;

摘要
探讨阿戈美拉汀与舍曲林对首发老年抑郁症的疗效比较。方法 选取首发老年抑郁症患者116例,随机分为观察组和对照组,每组58例。观察组给予阿戈美拉汀治疗,对照组给予舍曲林治疗。对两组临床疗效、睡眠改善情况及不良反应进行观察。结果 观察组自1周末起HAMD、PSQI评分即有显著下降(P<0.01),对照组自2周末起HAMD、PSQI评分才有显著下降(P<0.01)。第1、2、4、8周末观察组HAMD评分显著低于对照组(P<0.05),第4、8周末观察组PSQI评分明显低于对照组(P<0.05)。观察组服药期间不良反应发生率明显低于对照组(P<0.05)。结论 阿戈美拉汀治疗老年首发抑郁症起效快,不良反应少,改善失眠症状更优,值得推广与使用。
Abstract
Objective To compare the curative effect of agomelatine and sertraline in first-episode senile depression. Methods 116 patients with first-episode depression in the elderly patients, were randomly divided into observation group and control group, 58 cases in each group. The observation group received the treatment of agomelatine, the control group was given Seculin treatment. The clinical efficacy、 the improvement of bad sleep and adverse reactions of two groups were observed. Results At the end of 1 th week, scores of HAMD and PSQI decreased significantly (P<0.01) in observation group .At the end of 2th week, scores of HAMD and PSQI decreased significantly (P<0.01) in control group. At the end of the 1h、2th、4th、8th week, the scores of HAMD were significantly lower in observation group than control group. At the end of the 4th、 8th week,the scores of PSQI were lower in observation group than control group significantly (P<0.05)。The incidence rates of side effect in observation group were lower than in control group(P<0.05). Conclusion In the treatment of elderly patients with first-episode depression, agomelatine has advantages on onset time, less adverse reaction, improving insomnia better, it is worth promoting and using.
关键词
首发老年抑郁症;阿戈美拉汀;舍曲林
KeyWord
first-episode senile depression; Agomelatin; Sertralin
基金项目
页码 65-67
  • 参考文献
  • 相关文献
  • 引用本文

牛娟*,周田田,陈晓芹,于杨. 阿戈美拉汀治疗首发老年抑郁症的临床疗效研究 [J]. 国际精神病学杂志. 2018; 45; (1). 65 - 67.

  • 文献评论

相关学者

相关机构